Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02662387 · ClinicalTrials.gov registry record · NA
External Nasal Dilator and Oxygen Therapy in Respiratory Failure
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT02662387 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 55 participants.
The verdict
NCT02662387, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
Acute respiratory failure secondary to bronchiolitis and asthma is one of the most common diagnoses in children admitted to pediatric intensive care unit. Objectives: The primary outcome of the study is to compare the respiratory parameters between patients on HFNC and HFNC with ENDs. Methods: This is a prospective randomized controlled trial. All children admitted to Loma Linda University Children's Hospital due to acute respiratory failure secondary to bronchiolitis and asthma are eligible for inclusion in the study. Multiple respiratory parameters will be collected as part of the study. The investigators anticipate that use of END will have a positive impact on the respiratory status of children with acute respiratory failure. Appropriate statistical analysis of the data will occur after the data has been de-identified.
Interventions
- DEVICE External nasal dilator (END)
- OTHER High flow nasal cannula (HFNC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2016-02-02 |
| Est. Completion | 2016-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02662387
The ClinicalTrials.gov registry entry for NCT02662387 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which External nasal dilator (END) is the first listed.
NCT02662387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02662387 about?
NCT02662387 is a clinical study titled "External Nasal Dilator and Oxygen Therapy in Respiratory Failure". Acute respiratory failure secondary to bronchiolitis and asthma is one of the most common diagnoses in children admitted to pediatric intensive care unit. Objectives: The primary outcome of the study is to compare the respiratory parameters between patients on HFNC and HFNC with ENDs. Methods: Thi...
What is the current status of trial NCT02662387?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2016-02-02. Estimated completion is 2016-06-15.
What interventions are being tested in trial NCT02662387?
The interventions under investigation include: External nasal dilator (END) (DEVICE), High flow nasal cannula (HFNC) (OTHER).
Who is sponsoring clinical trial NCT02662387?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.